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Abstract. 
 
Retinoic acid is a signaling molecule in-
volved in the regulation of growth and morphogenesis 
during development. There are three types of nuclear 
receptors for all-
 
trans
 
 retinoic acid in mammals, 
RAR
 
a
 
, RAR
 
b
 
, and RAR
 
g
 
, which transduce the reti-
noic acid signal by inducing or repressing the transcrip-
tion of target genes (Leid, M., P. Kastner, and P. Cham-
bon. 1992. 
 
Trends Biochem. Sci.
 
 17:427–433). While 
RAR
 
a
 
, RAR
 
b
 
, and RAR
 
g
 
 are expressed in distinct but 
overlapping patterns in the developing mouse limb, 
their exact role in limb development remains unclear. 
To better understand the role of retinoic acid receptors 
in mammalian limb development, we have ectopically 
expressed a modified RAR
 
a
 
 with constitutive activity 
(Balkan, W., G.K. Klintworth, C.B. Bock, and E. Lin-
ney. 1992. 
 
Dev. Biol.
 
 151:622–625) in the limbs of trans-
genic mice. Overexpression of the transgene was associ-
ated with marked pre- and postaxial limb defects, 
particularly in the hind limb, where expression of the 
transgene was consistently seen across the whole an-
teroposterior axis. The defects displayed in these mice 
recapitulate, to a large degree, many of the congenital 
limb malformations observed in the fetuses of dams ad-
ministered high doses of retinoic acid (Kochhar, D.M. 
1973. 
 
Teratology.
 
 7:289–295). Further analysis of these 
transgenic animals showed that the defect in skeleto-
genesis resided at the level of chondrogenesis. Compar-
ison of the expression of the transgene relative to that 
of endogenous RAR
 
a
 
 revealed that downregulation of 
RAR
 
a
 
 is important in allowing the chondrogenic phe-
notype to be expressed. These results demonstrate a 
specific function for RAR
 
a
 
 in limb development and 
the regulation of chondroblast differentiation.
 
R
 
etinoic
 
 acid (RA)
 
1
 
 is an important signaling mole-
cule involved in the regulation of growth during
embryonic development and cell differentiation. In
the developing mammalian limb, RA affects the differenti-
ation of many cell lineages, including those of mesenchy-
mal and chondrogenic origin (Solursh and Meier, 1973;
Lewis et al., 1978; Zimmerman and Tsambos, 1985). RA is
important in normal limb ontogeny and in excess is a po-
tent teratogen, causing characteristic perturbations of nor-
mal limb development in a stage- and dose-dependent
manner (Shenefelt, 1972; Kochhar, 1973; Kwasigroch and
Kochhar, 1980). The timing of RA treatment and the re-
sultant limb defects appear to coincide with the timing of
mesenchyme condensation and differentiation into chon-
drocytes between embryonic day (E) 11 and E14 (Kwasi-
groch and Kochhar, 1980). RA treatment at earlier stages
(i.e., E9 to E10) has limited effects that are primarily re-
stricted to the digits and that have been attributed to
changes in the apical ectodermal ridge and the associated
underlying mesenchyme (Sulik and Dehart, 1988; Tickle et
al., 1989). At later stages (i.e., 
 
.
 
E14), RA treatment has
little or no effect on limb patterning and development.
Consistent with its role in mesenchyme growth and differ-
entiation, RA has dramatic effects on chondrogenesis of
limb mesenchyme in vitro and in vivo. Most of these ob-
served effects arise from changes in gene transcription me-
diated, in part, by the nuclear hormone receptors for RA.
There are two subfamilies of nuclear retinoid receptors
known to modulate the actions of RA. The RA receptors
(RARs) 
 
a
 
, 
 
b
 
, and 
 
g
 
, and the retinoid X receptors (RXRs)
 
a
 
, 
 
b
 
, and 
 
g
 
, both of which act as ligand-dependent tran-
scription factors through the formation of heterodimers
bound to specific RA response elements (RAREs) (for re-
view see Leid et al., 1992
 
a
 
; Linney, 1992; Giguère, 1994
and references therein). Both the RARs and RXRs are
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: E, embryonic day; RA, retinoic acid;
RAR, RA receptor; RXR, retinoid X receptor; tgRAR
 
a
 
, transgenic
RAR
 
a
 
.
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widely expressed in a number of fetal and adult tissues in
specific spatial and temporal patterns (Dollé et al., 1989
 
b
 
;
Krust et al., 1989; Zelent et al., 1989; Dollé, 1990; Ruberte
et al., 1990, 1991, 1993; Dollé et al., 1994).
In the developing murine limb, the RARs are expressed
in distinct and sometimes overlapping spatiotemporal
patterns. The RARs 
 
a
 
 and 
 
g
 
 are expressed in overlapping
regions during fore limb development from E9.5 to E11.5
(Dollé et al., 1989
 
b
 
; Ruberte et al., 1990). RAR
 
g
 
 then
becomes preferentially localized to the precartilage con-
densation and cartilage. In contrast, RAR
 
a
 
 expression
appears to progressively decrease during this chondro-
genic sequence and becomes primarily restricted to the
surrounding mesenchyme and interdigital zone, where it
is comparatively highly expressed (Dollé et al., 1989
 
b
 
).
RAR
 
b
 
 is expressed in the proximal mesenchyme early in
limb outgrowth and later is found in the interdigital zone
and in the interior, anterior, and posterior necrotic zones
(Dollé 1989
 
b
 
; Mendelsohn et al., 1991). Two of the pre-
sumptive heterodimeric partners for the RARs, RXR
 
a
 
,
and RXR
 
b
 
, are expressed ubiquitously throughout limb
development up to E16.5 (Dollé et al., 1994). In the devel-
oping chick limb, RAR
 
b
 
1 and RAR
 
b
 
2 have been shown
to exhibit distinct expression patterns during the differen-
tiation events associated with chondrogenesis. Initially,
RAR
 
b
 
1 expression is ubiquitous and not specifically lo-
cated to any region, while RAR
 
b
 
2 is restricted to the early
mesenchymal condensate in the limb core (Smith et al.,
1995). At later stages, RAR
 
b
 
2 is no longer detected in the
limb core, where chondrocytes have formed, but is re-
stricted to a thin cell layer lateral to the maturing cartilage.
Given the distinct spatiotemporal expression patterns
observed for each of the RARs during mouse embryogen-
esis and in adult tissues, it has been proposed that each re-
ceptor may perform unique functions during development
and homeostasis (for review see Chambon, 1994; Under-
hill et al., 1995 and references therein). Boylan et al. (1993,
1995), for example, have recently shown that targeted dis-
ruption of RAR
 
a
 
 and RAR
 
g
 
 in F9 embryonal carcinoma
cells results in receptor-specific alterations in RA-medi-
ated differentiation and RA metabolism. In the whole ani-
mal, however, the absence of any obvious abnormalities in
homozygous null fetuses for a number of receptors and
their isoforms suggests that there may be a high degree of
functional redundancy among members of the RAR fam-
ily (Li et al., 1993; Lohnes et al., 1993, 1994; Lufkin et al.,
1993; Kastner et al., 1994; Mendelsohn, 1994
 
a
 
,
 
b
 
; Sucov et
al., 1994). Their importance in limb development was
demonstrated by the observation that compound homozy-
gotes of null alleles of RAR
 
a
 
 and RAR
 
g
 
 exhibited a range
of limb abnormalities from reductions to duplications
(Lohnes et al., 1994). Hence, it appears that in early limb
development RAR
 
a
 
 is able to substitute for RAR
 
g
 
 and
vice versa, but at least one of the receptors is minimally re-
quired for proper limb development.
To evaluate the function of RAR
 
a
 
 in limb development,
we have generated transgenic mice that ectopically ex-
press a constitutively active form of human RAR
 
a
 
1 in the
developing limb under the control of a Hoxb-6 promoter
fragment. We have previously shown that mice expressing
this modified receptor in the eye under the control of the
 
a
 
A-crystallin promoter develop microphthalmia and cata-
racts, both of which are observed in mice treated with RA
in utero (Balkan et al., 1992
 
b
 
). Analysis of transgene ex-
pression in Hoxb-6 animals revealed two levels of expres-
sion in the developing limb. High levels of transgene ex-
pression throughout the limb bud produced a range of
phenotypic abnormalities that recapitulate many of the
congenital limb malformations observed in the fetuses of
dams administered high levels of RA, whereas animals
with low levels of transgene expression appeared normal.
Further analysis of these animals as described herein has
revealed that RAR
 
a
 
 is important in regulating chondro-
genesis in vivo.
 
Materials and Methods
 
Gel Mobility Shift Assay
 
A RAR
 
b
 
2 RARE double-stranded oligonucleotide probe was prepared
by annealing the following oligos: 5
 
9
 
 TCGAGGGTAGGGTTCAC-
CGAAAGTTCAC 3
 
9
 
 and 3
 
9
 
 CCCATCCCAAGTGGCTTTCAAGT-
GAGCT 5
 
9
 
. The probe was filled in using [
 
32
 
P]dCTP and Klenow DNA
polymerase. All proteins were purified using the pGEX-2T bacterial ex-
pression system (Pharmacia LKB Biotechnology, Piscataway, NJ) accord-
ing to the manufacturer’s instructions. Protein–DNA binding reactions
were carried out in 20 
 
m
 
l of binding buffer (10% glycerol, 10 mM Hepes,
pH 8.0, 50 mM KCl, 2.5 mM MgCl
 
2
 
, 1 mM ZnCl
 
2
 
, 1 mM DTT) containing
1 
 
m
 
g poly dI-dC and 0.15 
 
m
 
g of hRAR
 
a
 
 or hRAR
 
a
 
-CB with or without
0.15 
 
m
 
g of mRXR
 
b
 
 on ice for 10 min. After this preincubation, 0.1 ng of
labeled probe (67,000 cpm) was added to each tube, and the reactions
were allowed to proceed for an additional 20 min at room temperature.
Unlabeled probe (50 ng, 500
 
3
 
) was included in some reactions as a spe-
cific competitor. The samples were resolved on a prerun 4% nondenatur-
ing polyacrylamide gel at 4
 
8
 
C.
 
Generation of Transgenic Mice
 
The transgene was constructed in the pGEM9zf(
 
2
 
) derivative, pW1,
which contains a BamHI restriction site juxtaposed between the HindIII
and SpeI restriction sites and the polyadenylation sequence from SV-40 in
the NsiI site (Balkan et al., 1992
 
a
 
). A 3.3-kb fragment of the Hoxb-6 pro-
moter that contains sequences immediately upstream of the transcrip-
tional start site was liberated from pKSIIHoxb-6 (Schughart et al., 1991)
by restriction endonuclease digestion with EcoRI and BamHI and direc-
tionally subcloned into pW1, thereby generating pW1Hoxb-6. pW1Hoxb-
6tgRAR
 
a
 
1 was made by subcloning the constitutively active RAR
 
a
 
1
(Balkan et al., 1992
 
b
 
) into the BamHI restriction site of pW1Hoxb-6.
Hoxb-6tgRAR
 
a
 
1 DNA for microinjection was released from the vector
backbone using NotI and SfiI, separated on agarose gel, and gel purified
using geneclean (BIO 101, La Jolla, CA) according to the manufacturer’s
instructions. Transgenic mice were made by microinjection of C57Bl6F
 
1
 
/J-
(Jax Laboratories, Bar Harbor, ME) fertilized mouse eggs with DNA at a
concentration of 2–3 ng/
 
m
 
l. Mice that carried the transgene were identified
by slot-blot hybridization of tail DNA with an 
 
Escherichia coli
 
 
 
b
 
-galactosi-
dase DNA probe.
 
Analysis of Transgenic Mice
 
Embryos were stained for 
 
b
 
-galactosidase activity using a protocol de-
scribed by Balkan et al. (1992
 
a
 
). The morning of the day of the copulation
plug was considered E0.5.
Differential skeletal staining of embryos with alcian blue 8GS and al-
izarin red S was performed as described by McLeod (1980). Postterm mice
were stained using a similar protocol with extended periods of incubation.
Western analysis was performed using standard procedures. Hind limb
bud protein extracts were prepared from E11.5 animals. A cut parallel to
the body wall was made to release the limb buds, and hind limb bud pairs
from individual animals were transferred to 100 
 
m
 
l of treatment buffer
(0.125 M Tris-HCl, pH 6.8, 4% SDS, 20% glycerol, 10% 2-mercaptoetha-
nol) and boiled for 5 min with intermittent mixing. Protein extracts (10 
 
m
 
l
for J limbs, 20 
 
m
 
l for I limbs) were separated by SDS-PAGE and trans-
ferred to nitrocellulose. Blots were incubated with an anti–
 
b
 
-galactosidase
antibody (Promega Corp., Madison, WI) for 2 h and washed, and an anti– 
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mouse secondary antibody conjugated to alkaline phosphatase was added
for 1 h. Alkaline phosphatase activity was detected using a mixture of ni-
tro blue tetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate (Promega
Corp.) according to the manufacturer’s instructions.
 
Preparation of Micromass Cultures
 
Hind limbs of E11.5 embryos were collected aseptically and teased apart
into small pieces with forceps in Puck’s saline G buffer. Cells were dissoci-
ated by incubation in the presence of dispase (1 U/ml) (GIBCO BRL,
Gaithersburg, MD) with shaking at 37
 
8
 
C in Puck’s saline A buffer con-
taining 10% chicken serum. Digestion was terminated by resuspension in
SCM (60% Ham’s F12, 40% DME supplemented with antibiotics and
10% FBS) followed by gentle trituration to obtain a fine cell suspension.
Cells were passed through a No. 20 Nitex (Tetko Co., Elmsford, NY)
mesh to remove cell clumps and to obtain a single cell suspension. Cell
number was adjusted to 1 
 
3
 
 10
 
7
 
 cells/ml and micromass cultures were inti-
ated by carefully placing 10 
 
m
 
l of the cell suspension into the center of a
well in a 24-well plate. Cultures were placed in a 37
 
8
 
C incubator contain-
ing a humidified atmosphere and 5% CO
 
2
 
. After attachment (
 
z
 
1.5 h), 1 ml
of SCM was added to each culture, and cultures were returned to the incu-
bator. Media changes were performed at least once a day. Cultures were
incubated for a period of 1 to 6 d, at which time they were processed for
 
b
 
-galactosidase activity, and duplicate cultures were stained for the pres-
ence of sulfated glycosaminoglycans found in cartilage matrix using alcian
blue at acidic pH (Lev and Spicer, 1964). Alcian blue staining was carried
out as follows. Cells were washed twice with PBS, fixed for 15 min in
Kahle’s fixative, washed once with 0.1 N HCl, and stained overnight with
0.1% alcian blue in 0.1 N HCl. After staining, the cultures were washed
twice with 70% ethanol and stored in the same. Nodule numbers were de-
termined by counting the number of alcian blue–stained nodules within a
fixed area (3 mm
 
2
 
). Statistics were determined using the Student’s 
 
t
 
-test.
 
Synthesis of Hybridization Probes
 
Single-stranded RNA probes with incorporated digoxigenin were tran-
scribed from linear DNA templates according to manufacturer’s instruc-
tions (Boehringer Mannheim Corp., Indianapolis, IN). Probes were quanti-
fied by spotting various dilutions of probe in 10
 
3
 
 SSC (1.5 M NaCl, 150 mM
sodium citrate) and a control digoxigenin-labeled RNA on a nylon mem-
brane; detection of probe using a sheep anti–digoxigenin conjugated alka-
line phosphatase antibody (Boehringer Mannheim Corp.) was as de-
scribed by the manufacturer.
Probes for mRAR
 
a
 
 and mRAR
 
g
 
 were produced from templates that
included part of the 3
 
9
 
 coding and 3
 
9
 
 untranslated region of mRAR
 
a
 
 and
the 3
 
9
 
 DEF region of RAR
 
g
 
. Hybridization probes were synthesized from
linearized plasmid DNA templates using in vitro transcription. An 
 
z
 
600-
bp riboprobe for mRAR
 
a was made using T3 RNA polymerase and a
pKSII (Stratagene, La Jolla, CA) plasmid cleaved with EcoRV (cleaves in-
ternally) that carried a 2.2-kb mRARa insert. mRARg riboprobe was syn-
thesized from a pBS (Stratagene) template containing a 1.0-kb mRARg
insert that had been linearized with EcoRI.
Whole-Mount In Situ Hybridization
of Micromass Cultures
Whole-mount in situ hybridizations of micromass cultures were per-
formed as described by Conlan and Rossant (1992) with modifications.
Micromass cultures were washed twice with PBS and fixed in 4%
paraformaldehyde overnight at 48C. After fixation, cultures were washed
three times with cold PBS and dehydrated through a PBS/methanol series
to 100% methanol and stored in 75% methanol at 48C until use. Before
hybridization, cultures were rehydrated in PBT (PBS, 0.05% Tween-20)
and treated with proteinase-K for 6 min, washed twice with 2 mg/ml gly-
cine in PBT, and fixed for 20 min in 4% paraformaldehyde. Cultures were
washed three times with PBT and twice in hybridization buffer (50% for-
mamide, 0.75 M NaCl, 10 mM Pipes, pH 6.8, 1 mM EDTA, 100 mg/ml
tRNA, 0.05% heparin, 0.01% BSA, 1% SDS) and prehybridized for at
least 1 h at 558C. Hybridizations were carried out overnight at 558C in a
programmable dry oven (Bellco Glass Inc., Vineland, NJ) with 1 mg/ml ribo-
probe. Conditions for washing and antibody incubation were similar to
that previously described (Conlon and Rossant, 1992). Color development
was carried out overnight in the dark in 10% polyvinyl alcohol (Aldrich,
average mol wt 13,000–23,000) (Barth and Ivarie, 1994). Addition of poly-
vinyl alcohol was found to increase signal to noise ratio.
Results
Construction of Hoxb-6hRARa-LacZ Transgenic Mice
Transgenic mice were generated that expressed a consti-
tutively active human RARa1 (a chimeric receptor with
b-galactosidase fused to the carboxy terminus, denoted
tgRARa herein) (Balkan et al., 1992b) to high levels in the
developing limb. In vitro analysis of tgRARa binding to a
DNA probe containing the bRARE showed that efficient
binding was dependent upon the presence of an RXR het-
erodimer partner (Fig. 1), consistent with that observed
for wild-type RARs (Yu et al., 1991; Leid et al., 1992b).
The murine Hoxb-6 (Hox 2.2) promoter fragment, which
has been shown previously to direct expression of a LacZ
reporter gene to the developing limbs (Schughart et al.,
1991), was used to target expression of the fusion receptor
in the transgenic animals.
Transgenic mice carrying tgRARa under the control of
the murine Hoxb-6 promoter fragment were generated by
injecting one-cell embryos with the construct shown in Fig.
2 A. Owing to the presence of RAREs in several Hox pro-
moters (Langston and Gudas, 1992; Popperl and Feather-
stone, 1993; Marshall et al., 1994), we checked the ability of
both hRARa and tgRARa to trans-activate the Hoxb-6 pro-
moter fragment in transient expression assays. Neither
hRARa nor tgRARa was able to trans-activate the Hoxb-6
promoter fragment in the absence or presence of 500 nM
all-trans RA (data not shown). Screening of transgenic
mice was done by slot-blot hybridization of DNA isolated
Figure 1. hRARa and tgRARa exhibit similar DNA-binding prop-
erties. The ability of equivalent amounts of hRARa- and tgRARa
(hRARa-CB)-purified protein to shift a bRARE oligonucleotide
probe in the absence or presence of a RXRb partner are shown.
Note that on a molar basis, there is z2/3 less tgRARa than
hRARa protein and that the larger tgRARa protein results in re-
duced band mobility relative to hRARa.The Journal of Cell Biology, Volume 136, 1997 448
from mouse tails. 12 founders were generated and used to
establish eight lines of transgenic mice. Of the 12 founders
generated, four exhibited similar congenital limb malfor-
mations (A–D, see below), while eight (E–L) appeared
phenotypically normal. Original founders as well as male
and female progeny from all eight lines have been studied
extensively, and a range of phenotypic abnormalities have
been observed, depending on the level of transgene ex-
pression in the developing limbs.
The expression of tgRARa in the developing limbs of
embryos derived from the eight phenotypically normal
transgenic founders was analyzed in detail. At E10.5, the
transgene was expressed in the mesenchyme of the emerg-
ing limb buds and in the ventrolateral mesenchyme be-
tween the limb buds. In the fore limb bud, b-galactosidase
activity was restricted to the posterior region whereas the
entire hind limb bud expressed tgRARa (Fig. 2, B and D).
While no differences in the transgene expression pattern
were seen between the eight lines, significant differences
in tgRARa expression levels were observed. In three of
the eight lines (J, K, and L), tgRARa was expressed at
high levels in the posterior half of the fore limb and across
the entire hind limb (Fig. 2 B). In the other five lines (E–I),
however, low levels of transgene expression were seen in
both the fore and hind limbs (Fig. 2 D). At E11.5, differ-
ences between the two levels of transgene expression per-
sisted, which was further confirmed by Western analysis
with an anti–b-galactosidase antibody (data not shown).
Specifically, in the hind limbs of embryos derived from
high expressing founders, transgene expression was seen
across the whole anteroposterior axis and extended dis-
tally into the progress zone (Fig. 2 C). In embryos derived
from low expressors, tgRARa expression was restricted to
anterior and posterior stripes in the mesenchyme of the
developing hind limb with no significant expression of the
transgene in the progress zone of the fore or hind limb
(Fig. 2 E). Tissue sections from E12.5 high expressor hind
limbs confirmed that transgene expression was not present
in the ectoderm but was present in chondrogenic conden-
sations that will become the tibia and fibula and strongly
expressed in the underlying mesenchyme, including the
progress zone (data not shown). These results are summa-
Figure 2. Structure and expression of the Hoxb-6tgRARa fusion
gene construct. (A) A 9-kb linear DNA fragment containing the
Hoxb-6tgRARa fusion gene was excised from a pGEM9zf(2)
parent plasmid with SfiI and NotI and used for microinjection
into fertilized eggs. (B–E) Expression patterns of the transgene in
E10.5 and E11.5 mouse embryos. (B and C) tgRARa is expressed
at high levels within the developing limbs at E10.5 (B) and E11.5
(C) in the three transgenic lines in which limb malformations
were seen. A representative progeny from founder male J is
shown. (D and E) The chimeric receptor is expressed at a lower
level in the developing limbs at E10.5 (D) and E11.5 (E) in the
five transgenic lines in which no limb malformations were ob-
served. A representative progeny from founder male I is shown.
Figure 3. Limb malformations seen in Hoxb-6tgRARa trans-
genic mice. Hemizygous animals from independent transgenic
lines showed strong skeletal malformations affecting both the
fore and hind limbs, with variability in the severity of the malfor-
mations seen both between and within transgenic lines. Three
2-wk-old animals from a litter derived from founder male J are
shown to illustrate the range of limb malformations seen. The an-
imal on the left exhibits strong skeletal malformations affecting
both the fore and hind limbs, while only the hind limbs of a litter-
mate (center) are grossly malformed. A nontransgenic littermate
(right) is shown for comparison. Note the overall difference in
size between the normal and transgenic animals.Cash et al. RARa and Inhibition of Chondrogenesis 449
rized in Table I. Furthermore, a transgenic line that ex-
pressed a potent dominant-negative RAR to a level simi-
lar to that of the high transgene-expressing lines described
herein exhibited no perceptible phenotype suggesting that
the tgRARa is not functioning in a dominant-negative
manner (our unpublished observations).
While founders J, K, and L were phenotypically normal,
they did pass the transgene in a Mendelian fashion to their
progeny, and all transgene positive offspring exhibited
limb malformations like those seen in the four affected
founders (Fig. 3). Because some founder males with limb
malformations had difficulty mating, lines established
from male J and female L were relied upon for most of the
analysis of the effects of ectopic tgRARa expression on
limb development. Interestingly, no limb malformations
were observed in the offspring of the five phenotypically
normal founders (E–I) with the lower levels of tgRARa
expression, suggesting that high level expression of the fu-
sion receptor is required for alterations in normal limb de-
velopment.
Consequences of Hoxb-6tgRARa Transgene Expression
The limb malformations associated with expression of the
transgene were analyzed in detail in embryos and animals
derived from a representative line (J) (Figs. 4 and 5); simi-
lar malformations were seen in four founders and two
other independent transgenic lines. Pronounced bilateral
defects were always present in the hind limb, whereas de-
Table I. Summary of Transgenic Lines Generated
Founder
Limb
phenotype
Transgene
expression
level
Affected
progeny
A (M) yes ND ND
B (ND) yes ND ND
C (F) yes ND ND
D (F) yes ND ND
E (M) no L no
F (M) no L no
G (M) no L no
H (M) no L no
I (M) no L no
J (M) no H yes
K (M) no H no*
L (F) no H yes
M, male; F, female; L, low; H, high; *, low germline transmission.
Figure 4. Alizarin red S– and alcian blue–stained preparations of
left fore limb skeletons from normal and transgenic 2-wk-old
mice. All skeletons were stained with alizarin red S (a bone-spe-
cific stain) and alcian blue (a cartilage-specific stain). (A) Dorsal
view of a normal fore limb. (B) Close-up of the carpal region
shown in A. (C) Dorsal view of a mildly affected transgenic fore
limb. The ulna is slightly thickened and foreshortened. (D)
Close-up of the carpals shown in C; note that the fifth metacarpal
is reduced to a small nodule with no corresponding phalanx (ar-
row). (E) Dorsal view of a severely affected transgenic fore limb.
The ulna is dramatically thickened, foreshortened, and postaxi-
ally deflected, and the fourth distal phalanx is duplicated (arrow-
heads). (F) Close-up of the carpal area in E. r, radius; u, ulna; h,
humerus.
Figure 5. Alizarin red S– and alcian blue–stained preparations of
left hind limb skeletons from normal and transgenic newborn an-
imals and 2-wk-old mice. All skeletons were stained as in Fig. 3.
(A) Lateral view of the hind limb of a normal newborn. (B) Lat-
eral view of the hind limb of a transgenic newborn showing the
missing fibula and rotated ankle and foot. (C) Lateral view of the
hind limb of a normal 2-wk-old animal. (D) Ventral view of the hind
limb of a transgenic 2-wk-old animal showing the cartilaginous
remnant of the fibula and the mildly shortened and misshapen
tibia. The foot is rotated z1808 postaxially out of its normal plane.
(E) Close-up of the ankle shown in C, dorsal view. (F) Close-up
of the ankle shown in D, dorsal view. t, tibia; fb, fibula; fe, femur.The Journal of Cell Biology, Volume 136, 1997 450
fects in the fore limb were variable. In the affected ani-
mals, there was a predilection towards the loss of postaxial
structures, and, in general, the degree of postaxial deflec-
tion in the fore limb appeared to be a good indicator of the
severity of the defect.
Malformations in the fore limb (Fig. 4) were primarily
restricted to the field of transgene expression that in-
cluded the ulna, ulna carpal bone, and their respective ar-
ticulating bones. Although the transgenic animals exhib-
ited a marked variability in the severity of the defect in the
fore limbs, all the transgenic animals contained a de-
formed ulna, which varied from mild with a slight postaxial
curvature to severe. The ulna in the severely affected ani-
mals was dramatically thickened (in some cases to twice
that of the size of the radius), postaxially deflected, and
foreshortened (compare Fig. 4, A and E). In comparison,
the radius and humerus appeared to be only mildly af-
fected. Furthermore, the radius was always found to be
longer than the ulna, and the degree of this disparity ap-
peared to correlate well with the amount of postaxial
bending, suggesting that the disproportionate growth of
the ulna and the radius in the proximodistal axis most
likely contributed to the postaxial deflection. Malforma-
tions in the wrist consisted of a reduction in the size of the
ulnar carpal and fourth carpal bone with the loss of the
fourth carpal–fifth metacarpal articulating surface (Fig. 4,
D and E). The pisiform bone also appeared to be some-
times absent or not mineralized. Most of the metacarpals
were shortened, and in some of the mildly affected ani-
mals, metacarpal 5 was reduced to a mineralized nodule
with no corresponding phalanx (Fig. 4 D). Additionally, in
some of the more severely affected animals we periodi-
cally observed a very broad fourth medial phalanx with
a complete duplication of the fourth distal phalanx (Fig.
4 E).
Founders A, B, C, and D, as well as those transgenic an-
imals derived from founder J, all exhibited bilateral hind
limb malformations (Fig. 5). In all animals examined, the
fibula was malformed; this ranged from complete absence,
except for a small distal nodule, to thickened partial fibu-
las that extended more proximally (Fig. 5, B and D). In ad-
dition, the extent of the fibular defect was found to be
nearly perfectly symmetrical and to be 100% penetrant,
with variability in the degree of severity of the effect on
the foot and ankle. No proximal fibula–associated struc-
tures were observed using alizarin red or alcian blue stain-
Figure 6. Analysis of the chondrogenic sequence in hind limbs of control and transgenic fetuses. Control fetuses are shown in A, and
Hoxb-6tgRARa fetuses are shown in B. Whole-mount alcian blue and alizarin red stainings of hind limbs are shown at five successive
developmental stages: E13.5, E15.5, E17, E17.5, and E18. 1–5, digit numbers; 19, extra digit 1.Cash et al. RARa and Inhibition of Chondrogenesis 451
ing. In contrast, the tibia was found to be only marginally
affected, exhibiting a dorsal curvature and slight shorten-
ing and thickening. The calcaneus was found to be reduced
in size, displaced laterally to the outside of the fibula, and
missing an articulation surface for the fifth metatarsal. In
some animals, the navicular and the cuboidum were found
to be fused to the second and third tarsals, respectively.
Occasionally, the fifth proximal and medial phalanges
were missing, with the presence of the distal phalanx (Fig.
5 F). As observed in the fore limb, the defects in the hind
limb appear to be primarily restricted to the posterior half
of the limb and to involve the distal long bones and proxi-
mal foot bones.
To establish that the transgene does not have nonauton-
omous effects on chondrogenesis in regions where it is not
expressed, the axial bones of transgenic and control ani-
mals were stained with alizarin red and alcian blue. No sig-
nificant differences were observed in these bones between
control and transgenic animals of similar embryonic age
(data not shown).
To understand what changes have occurred during de-
velopment of the limb to give rise to the aforementioned
malformations, a series of E13.5 through E18 fetuses were
collected and stained with alizarin red and alcian blue (Fig.
6). Transgenic animals were readily distinguishable from
their nontransgenic littermates as early as E11.5. The hind
limbs of the transgenic animals were somewhat smaller
and contained a disproportionately large outgrowth in the
region of the anterior margin, which will give rise to digit 1
(data not shown). Similar outgrowths are also observed in
the chick limb bud after placement of an RA-soaked bead
in the anterior margin (Summerbell, 1983). At later times
in development, digit 1 was found to be duplicated,
thereby generating a 1, 1, 2, 3, 4, 5 digit pattern (Fig. 6 B,
E15.5, E17, and E17.5). This duplication was seen in
z40% of the animals, and the extent of the duplication
correlated well with the size of the outgrowth. In most in-
stances, this duplicated digit was not maintained, as an
analysis of many (n . 200) adult animals revealed no such
digit duplication. As can be seen from the embryonic
panel, the digit duplication appears to be lost during the
course of development with the duplicated digit 19 becom-
ing fused with digit 1 (Fig. 6 B, E17 and E18). This was ev-
ident in the hind limbs of the adult animals, where digit 1
appeared to be composed of several individual and over-
lapping bones (Fig. 5 F).
Figure 7. Chondrogenesis of the tibia and fibula is delayed in Hoxb-6tgRARa mice. (A–D) Histological sections prepared from E13.5
control (A and C) and transgenic (B and D) fetuses. (A) In control animals, both the tibia and fibula are well defined by the perichon-
drium, and a close-up of the fibula (C) shows an abundance of oval-shaped maturing chondrocytes. (B) In contrast, the tibia and fibula
from transgenic animals are not as well organized, and a close-up of the fibula (D) shows that it is primarily composed of tightly packed
mesenchymal cells. t, tibia; fb, fibula; p, perichondrium; c, maturing chondrocytes.The Journal of Cell Biology, Volume 136, 1997 452Cash et al. RARa and Inhibition of Chondrogenesis 453
Development of the various elements of the hind limb
of transgenic animals was significantly delayed in compari-
son to wild-type animals. This was most apparent at later
embryonic stages, where ossification of the proximal pha-
langes of the hind limbs from transgenic animals was ob-
served to be at least 0.75–1 d behind that of wild-type ani-
mals. However, earlier in development the disparity in the
size of the limbs was also evident; in this case, the bone
primordia were shortened and slightly misshapen. Analy-
sis of hind limb histological sections prepared from E13.5
fetuses revealed that chondrogenesis of the tibia and fib-
ula was delayed in transgenic animals (Fig. 7). The primi-
tive fibula of the wild-type animals contained maturing
chondrocytes circumscribed by a well-defined perichon-
drium. In contrast, the fibula from transgenic animals was
not as well organized. The fibula was primarily composed
of closely packed chondroprogenitor cells with a lower cy-
toplasmic/nuclear ratio with a morphology consistent with
condensed mesenchymal cells. Chondrogenesis of the digi-
tal rays were also found to be delayed in the transgenic an-
imals (data not shown). Hence, overexpression of tgRARa
appeared to inhibit or interfere with chondrogenesis in the
hind limb by delaying chondroprogenitor differentiation.
Assessment of Chondrogenic Potential of
Transgene-expressing Mesenchymal Cells
To examine more thoroughly the defect in transgenic ani-
mals that interferes with chondrogenesis in endochondral
bone formation, the ability of the mesenchyme from trans-
genic limbs to form cartilage nodules was assayed in vitro
using micromass culturing methods. Limb mesenchyme
cultured under micromass conditions closely follows the
progression of limb mesenchyme in vivo, precartilaginous
condensations are first evident after 2 d in culture with
cartilage nodules appearing z1 d later (Ahrens et al.,
1977). Cultures were seeded at high density (1 3 105 cells/
10 ml) in a 24-well plate with dissociated limb mesenchyme
pooled from either fore or hind limbs of E11–11.25 trans-
genic or non-transgenic embryos. These cultures were al-
lowed to grow for up to 3, 4, or 6 d. Cartilage matrix pro-
duction was assayed for by fixing and staining the cultures
with alcian blue at low pH , while both the extent and dis-
tribution of transgene-expressing cells were determined by
staining fixed cultures with X-gal.
Within 3 d, cultures initiated from wild-type fore or hind
limb buds showed numerous well-defined alcian blue–
stained cartilage nodules (Fig 8, A and B). No alcian blue
nodules were observed in cultures after 2 d; instead, both
fore limb and hind limb cultures contained numerous con-
densations (data not shown). Similar to wild-type cultures,
transgenic fore and hind limb micromass cultures after 2 d
displayed many condensations (data not shown). Trans-
gene-expressing cells were found to be distributed through-
out the cultures and within condensations. In the hind limb
cultures, the transgene-expressing cell was the predomi-
nant cell type found within the condensations, while in the
fore limb there was a mixture of cells, with some conden-
sations being devoid of transgene-expressing cells. The
number of transgene-expressing cells from fore limb–
derived cultures were much lower than those of the hind
limb cultures, which is consistent with the differences ob-
served in transgene expression between the fore and hind
limb buds in vivo.
In contrast to wild-type cultures, cultures initiated from
the hind limb buds of transgenic animals exhibited few if
any alcian blue–stained nodules at 4 d (Fig. 8 C) and only
slightly more nodules (,5) at 6 d postinitiation (Fig. 8 G).
Examination of these cultures with dark-field microscopy
confirmed the absence of any apparent nodules or discrete
condensations (data not shown). In contrast, cultures initi-
ated from the fore limbs of transgenic animals displayed
numerous well-defined alcian blue–stained cartilage nod-
ules after 4 d (Fig. 8 A) and slightly more after 6 d (Fig. 8
G). However, their appearance was delayed and their
number was significantly reduced in comparison to wild-
type cells (Fig. 8 G). In addition, the nodules were mostly
confined to those regions containing nontransgene-express-
ing cells (Fig. 8 E). Furthermore, the differences in chon-
drogenesis observed between the cultures of fore and hind
limb buds from transgenic animals correlated well with the
observed differences in the severity of fore and hind limb
malformations seen in these animals. It should be noted
that the transgene continued to be abundantly expressed
throughout the culture period in both fore- and hind limb–
derived cultures (Fig. 8, E and F), and that there was no
Figure 8. Analysis of chondrogenic capacity of limb mesenchyme from the fore and hind limb of E11.25 transgenic embryos in compar-
ison to E11.25 wild-type embryos in micromass culture. In control fore (A) and hind limb (B) cultures, there are numerous well-defined
alcian blue–stained cartilage nodules, whereas in fore (C) and hind limb (D) cultures initiated from limb mesenchyme of transgenic ani-
mals, there are much fewer alcian blue–stained cartilage nodules relative to that of the control cultures. Cultures were stained with al-
cian blue after 3 d and counterstained with eosin/phloxine. Transgenic fore (E) and hind limb (F) cultures were fixed and stained with
X-gal after 4 d and counterstained with eosin/phloxine. The cartilage nodules appear pink, while the transgene-expressing cells appear
blue. Note that the nodules (white arrows) in the fore limb cultures contain very few if any transgene-expressing cells and that after 4 d
in culture, there are numerous transgene-expressing cells, which were especially apparent in the hind limb cultures. All pictures taken at
the same magnification of 503. (G) Quantification of the number of cartilage nodules seen in each group after 4 and 6 d in culture. The
number of cartilage nodules observed in the transgenic cultures is significantly less (P , 0.0001) than the number of nodules observed in
the corresponding wild-type culture both after 4 and 6 d of culture. Bar: (A–F) 0.2 mm.
Figure 9. Examination of RARa and RARg gene expression in 4-d wild-type micromass cultures with whole-mount in situ hybridiza-
tion. RARa (A and C) expression is found throughout the culture circumscribing the individual nodules (white arrow), but it is not
found within the core of the nodules that contain chondroblasts. In contrast, RARg (B and D) is strongly expressed within the core of
the nodules (white arrow) and to a lesser extent in the surrounding mesenchyme. The black arrows denote the edge of the culture. Up-
per panel, 153 magnification; lower panel, 753 magnification. Bar: (A and B) 1 mm; (C and D) 0.2 mm.The Journal of Cell Biology, Volume 136, 1997 454
significant growth disparity between wild-type and trans-
genic cultures. Consistent with the above in vivo observa-
tions, these results suggest that expression of tgRARa de-
layed or inhibited chondroblast differentiation subsequent
to condensation.
Analysis of RARa and RARg Gene Expression in 
Micromass Cultures
Previous studies have shown that RARa and RARg are
expressed throughout the fore limb mesenchyme between
E9.5–E11.5, at which time RARg expression becomes re-
stricted to precartilage and cartilage (Dollé et al., 1989b;
Ruberte et al., 1990). Whole-mount in situ hybridization
methodologies were adapted to the analysis of gene ex-
pression in micromass cultures so that the expression of
endogenous RARa could be compared to tgRARa. In
agreement with previous studies, by day 4 of culture,
RARg was found to be expressed in the core of the nod-
ule, where chondroblasts surrounded by cartilaginous ex-
tracellular matrix were observed (Fig. 9, B and D). RARa,
on the other hand, was found to be expressed in the pe-
ripheral region of the nodule in condensed mesenchymal
cells that had not yet differentiated into chondroblasts
(Fig. 9, A and C). RARa expression was either absent or
expressed at very low levels within the core of the nodule,
in chondroblasts (Fig. 9, A and C).
Discussion
Transgenic animals that ectopically express a constitu-
tively active hRARa1 in the developing murine limb ex-
hibited a spectrum of defects that included polydactyly,
syndactyly, ectrodactyly, fibular deficiencies, and tarsal
and carpal fusions. The phenotypes observed in these ani-
mals are similar to those that have been observed in a
number of vertebrate systems in which embryos were ad-
ministered systemic or localized doses of RA (Shenefelt,
1972; Kochhar and Aydelotte, 1973; Summerbell, 1983;
Tickle et al., 1985, 1989). A number of different roles have
been proposed for the function of the RARs during limb
development (Mendelsohn et al., 1991, 1992), some of
which include precartilage and cartilage formation, apop-
tosis, and patterning of the limb. We have found that
RARa is an important regulator of chondrogenesis during
limb development.
Transgene Expression and Chondrogenesis
The RARs are ligand-activated receptors that function as
heterodimers. Hence, transgene activity would rely on the
presence of a suitable heterodimeric partner. This condi-
tion is satisfied during the period of transgene expression
before overt cytodifferentiation (E13–13.5) within the
limb. RXRa and RXRb are expressed throughout the limb
mesenchyme at these stages and as such could provide a
suitable heterodimeric partner for the transgene.
Postnatal transgenic lines that expressed the transgene
to high levels during limb development (E9.5–E15) pre-
sented with a number of paraxial skeleton deficits, while
no apparent phenotype was observed in transgenic lines
expressing the transgene to a lower level. Although the ex-
pression patterns for the transgene in the two lines were
similar, the transgene in the high expressing lines is ex-
pressed to a much greater level relative to that of the low
expressing lines in the core mesenchyme (along the me-
dian axis). This mesoderm will contribute to the future
skeletal elements, suggesting that transgene expression in
this region may intefere with skeletogenesis and contrib-
ute to the observed defects. Consistent with these obser-
vations, the limb defects became first evident during em-
bryogenesis within the early stages of skeletogenesis (E13.5)
during formation of the cartilaginous template. Further-
more, histological sections prepared from E13.5 limbs
from transgenic and a nontransgenic littermate confirmed
that development of the limb cartilage was significantly
delayed in the transgenic animals. Taken together, these
observations suggested that expression of the transgene
interfered with chondrogenesis.
Micromass cultures have been previously shown to
closely follow those events of chondrogenesis in vivo and
have been used to study the role of various molecules in
chondrogenesis during endochondral bone formation. Car-
tilage nodules are first evident as a coalescence of meso-
derm cells that form a condensation. These aggregates con-
tinue to expand both by cell division and selective recruitment
of neighboring cells. After a period of cellular growth,
cells within the interior of the condensation begin to dif-
ferentiate and elaborate cartilage matrix that can be spe-
cifically stained with alcian blue. Micromass cultures de-
rived from wild-type and transgenic hind limbs appear
similar up to z2–2.5 d. Before this time, there is a similar
number of well-defined condensations in both cultures. It
is at the onset of chondroblast differentiation when differ-
ences between the two cultures become readily visible. In
the wild-type cultures, chondroblasts begin to appear within
the core of the condensations after 3 d in culture as shown
by alcian blue staining for cartilage matrix. Whereas, in
transgene-expressing cultures, especially those from hind
limbs, little or no alcian blue staining is observed after 4 or
6 d in culture, which is indicative of an absence of chon-
droblast differentiation and elaboration of extracellular
cartilage matrix. Hence, transgene expression appears to
interfere with the transition from a committed chondro-
progenitor cell, found within condensing mesoderm, to a
chondroblast located within the core of the nodule.
Analysis of RARa gene expression in micromass cul-
tures after 4 d has shown that RARa mRNA is absent in
the core of the nodules but is abundantly expressed in the
condensing mesoderm. Therefore, RARa mRNA is down-
regulated during chondroblast differentiation. In contrast,
RARg appears to be upregulated in the core of the nod-
ules in concert with chondroblast differentiation. In cul-
tures initiated from transgene-expressing limb mesen-
chyme, RARa is found to be abundantly expressed in
condensing mesoderm throughout the culture period and
continues to be expressed within the core of condensations
well after endogenous RARa expression is downregu-
lated. Together these results suggest that continued ex-
pression of RARa during mesoderm-chondroblast differ-
entiation interferes with the appearance of chondroblasts.
Hence, downregulation of RARa appears to be a neces-
sary step in chondroblast differentiation (Fig. 10). This
model has consequences for both understanding the roleCash et al. RARa and Inhibition of Chondrogenesis 455
of the receptors in teratogenesis as well as in the pheno-
types observed in RAR null mutants.
Transgenic Mice Exhibit Phenotypes Consistent with 
RA Treatment
RA has been shown to modify limb development in a
number of phylogenetically distinct species (Tabin, 1991;
White et al., 1994). Many of the phenotypes associated
with overexpression of tgRARa in the developing limb
are similar to those observed in the fetuses of dams treated
with teratogenic doses of RA. RA teratogenesis causes a
spectrum of defects within the limbs that are most com-
monly reductionist in nature and are thought to be, in part,
a consequence of a delay in chondrogenesis (Kwasigroch
and Kochhar, 1980; Zimmerman and Tsambos, 1985; Kwa-
sigroch et al., 1986). These malformations include, within
the hind limb, fibular agenesis, brachypodism, syndactyly,
ectrodactyly, bowing of the tibia, and syntosis of the
zeugopods (Shenefelt, 1972; Kochhar, 1973; Kochhar and
Aydelotte, 1974). All of these defects are found to varying
extents in the hind limbs of the tgRARa transgenic mice
described herein.
Several studies have shown that RA inhibits chondro-
genesis and that this inhibition is most likely RAR-medi-
ated (Eckhardt and Schmitt, 1994; Von Schroeder et al.,
1994). Further studies with receptor-specific agonists have
shown that an RARa-specific agonist is significantly more
potent in inducing limb malformations than either RARb-
or RARg-specific agonists (Elmazar et al., 1996). RARg is
expressed during chondrocyte maturation, whereas RARa
and RARb are not; RARa appears to be expressed in
most other tissues of the developing limb. Therefore, un-
der conditions of retinoid excess where expression of
RARb (Mendelsohn et al., 1991; Jiang et al., 1994) and
possibly RARa (both genes are RA responsive) are ele-
vated within the limb mesenchyme, a delay or inhibition of
chondroprogenitor differentiation could ensue, thereby in-
terfering with normal skeletogenesis. No differences in the
expression of RARb were observed between the limbs of
tgRARa transgenic mice and wild-type animals (our un-
published observations), and expression was restricted to
the anterior and posterior necrotic zones and in the inter-
digital spaces, suggesting that RARb is not contributing to
the observed phenotype in the transgenic mice.
Application of RA to the anterior margin of the devel-
oping chick limb has been shown to induce digit and skele-
tal element duplications (Tickle et al., 1982). Minor digit
duplications are apparent in the transgenic animals de-
scribed herein. Duplications were observed in the fourth
distal phalanx within the forelimb and digit 1 in the hind
limb. Both of these duplications occurred at the anterior
boundary of transgene expression: digit 4 in the fore limb
and digit 1 in the hind limb. Numerous genes have been
shown to be important in outgrowth and patterning of the
vertebrate limb, and some of these include sonic hedgehog
(Riddle et al., 1993), HoxD cluster (Dollé et al., 1989a),
and fibroblast growth factors (Niswander et al., 1993,
1994). Analysis of the expression patterns of sonic hedge-
hog, fibroblast growth factor 4, and Hoxd9 through d12
mRNAs with whole-mount in situ hybridization showed
no dramatic changes between transgenic and control ani-
mals; staining patterns were found to be consistent with
those reported by others (our unpublished observations).
These results suggest that the change in patterning ob-
served in the transgenic animals may not involve changes
in the expression of one of these gene products, or because
the duplications are relatively minor (fourth distal phalanx
in the fore limb and periodic partial digit 1 duplication in
the hind limb), any changes in expression of these genes
might be fairly subtle and therefore difficult to detect.
Recently, mice have been made with null alleles of
RARa, RARb, RARg, and RXRa (Lohnes et al., 1993;
Lufkin et al., 1993; Sucov et al., 1994; Luo et al., 1995).
Mice homozygous for either mutant allele do not show any
phenotype in the paraxial skeleton, whereas mice homozy-
gous for both, (RARa2/2, RARg2/2), have severe limb
malformations (Lohnes et al., 1994). The limbs of these
animals display proper anteroposterior symmetry, suggest-
ing that the primary defect is not at the level of pattern
formation (Lohnes et al., 1994). With the exception of the
RXRa null mice, treatment of RAR null embryos with
teratogenic doses of RA results in limb defects compara-
ble to that seen in heterozygous or wild-type embryos. The
observation that RXRa null mutants are resistant to RA-
induced limb defects underscores the importance of
RXRa as an integral component of the RA signaling cas-
cade in vivo (Sucov et al., 1995). It is interesting to note
that in both RARa/RARb2 and RARa/RARg null mice,
the mice display ectopic cartilages in a number of sites
throughout the animal. Furthermore, ectopic cartilages
were sometimes present in the interdigital region, and the
synovial joints were poorly defined in RARa/RARg null
mice. Given that the presence of RARa and possibly the
other RARs may be important in regulating cartilage for-
mation, this suggests that their absence creates permissive
conditions and could be expected to give rise to ectopic
cartilages, as observed in these animals.
We have provided evidence that the loss of RARa ex-
pression appears to be an important regulatory compo-
nent of mesoderm differentiation into chondroblasts in
that chondroprogenitor cells that express RARa failed to
differentiate into chondroblasts. Continued expression of
Figure 10. Loss of RARa expression is required for the chondro-
blast phenotype to be expressed. Mesenchymal cells are pluripo-
tent and contribute to a number of cell lineages in the developing
limb (e.g., muscle, cartilage, loose connective tissue, etc.). Cells
that become committed to a chondrogenic fate express RARa
and RARg before chondroblast differentiation RARa expres-
sion is decreased. Transgenic mice in which RARa is placed un-
der the control of the Hoxb-6 promoter continue to express
RARa during chondroprogenitor-chondroblast differentiation.
These animals display a number of limb malformations because
of an inhibition of chondrogenesis, specifically chondroblast dif-
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RARa in cells destined to become chondroblasts contrib-
utes to a different cellular fate, which is currently under in-
vestigation. Overall, downregulation of the RARs may be
an important determinant in regulating cellular differenti-
ation which has practical implications in understanding
their role in normal and abnormal development.
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